Skip to content

The effects of trigger point dry needling dosage on functional outcomes of the lateral elbow

Optimal duration of a single session of dry needling to the common extensor mass of the forearm in adults with lateral epicondylalgia (tennis elbow) for functional outcomes of pain, muscle extensibility, and strength

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10412631
Enrollment
80
Registered
2024-09-26
Start date
2024-01-03
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, forearm extensor muscle extensibility, and strength for adult patients with lateral epicondylalgia Musculoskeletal Diseases

Interventions

Current Interventions as of 24/06/2025: Before participants are selected, they will be screened for the exclusion criteria completed via the phone by a student physical therapist before committing to

Sponsors

Franklin Pierce University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Over the age of 18 years old 2. Diagnosis of lateral epicondylalgia per positive provocation using Cozen's and Maudsley's special tests

Exclusion criteria

Exclusion criteria: 1. Those who have received dry needling or physical therapy within the last 6 months for lateral epicondylalgia 2. Allergy to metals 3. Needle phobia 4. Blood clotting disorders 5. Recent infections 6. Diabetes 7. Peripheral neuropathy 8. Pregnant

Design outcomes

Primary

MeasureTime frame
The following primary outcome measures are assessed at baseline, 5 minutes, and 30 minutes post-intervention: 1. Pain measured via the pain pressure threshold using a dolorimeter 2. Grip strength measured using a handheld grip dynamometer 3. Wrist flexion passive range of motion measured using a goniometer

Secondary

MeasureTime frame
As of 24/06/2025: There are no current secondary outcome measures. Previous secondary outcome measures: Self-perceived disability measured using the QuickDash self-reported outcome survey before the intervention to establish a baseline level of functional impairment

Countries

United States of America

Contacts

Public ContactTamara Hefferon
thefferon@impactptaz.com+1(0) 623 208 7575

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026